Clinical Pharmacology of Oral Antidiabetic Agents
- 7 April 1977
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 296 (14) , 787-793
- https://doi.org/10.1056/nejm197704072961405
Abstract
Treatment with Oral Hypoglycemic AgentsThe main justifications for clinical use of oral hypoglycemic agents are that they are taken by mouth once or twice a day, making them more convenient and acceptable to the patient than insulin, that they are effective in lowering the blood glucose, and that they are safe. The first is self-evident, but the other two reasons for use deserve close examination.Efficacy in Lowering Blood GlucoseBoth the sulfonylureas and the biguanides acutely lower blood glucose. The more important consideration is whether or not the glucose-lowering effect is maintained during prolonged use. In other words, . . .This publication has 17 references indexed in Scilit:
- Diuretic Action of Three Sulfonylurea DrugsAnnals of Internal Medicine, 1973
- A Summary of Criticisms of the Findings and Conclusions of the University Group Diabetes Program (UGDP)Diabetes, 1972
- Drug-induced Hypoglycemia: A Review Based on 473 CasesDiabetes, 1972
- Sulfonylureas: Effects in Vivo and in VitroAnnals of Internal Medicine, 1971
- Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin resultsPublished by American Medical Association (AMA) ,1971
- Long-Term Experience with Sulfonylureas and PlaceboNew England Journal of Medicine, 1967
- Nine years' experience with tolbutamide in the treatment of diabetesMetabolism, 1966
- The long-term effect of tolbutamide on glucose tolerance in adult, asymptomatic, latent diabeticsMetabolism, 1965
- Long-term Observations on Oral Hypoglycemic Agents in Diabetes: The Effect of Carbutamide and TolbutamideDiabetes, 1965
- Incidence and Causes of Secondary Failure in Treatment with TolbutamideJAMA, 1962